Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients.
about
The Interplay Between Monocytes/Macrophages and CD4(+) T Cell Subsets in Rheumatoid ArthritisElevated soluble CD163 plasma levels are associated with disease severity in patients with hemorrhagic fever with renal syndromePre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patientsExpression of phosphocitrate-targeted genes in osteoarthritis menisci.Serum 14-3-3η level is associated with severity and clinical outcomes of rheumatoid arthritis, and its pretreatment level is predictive of DAS28 remission with tocilizumabCD56+ monocytes have a dysregulated cytokine response to lipopolysaccharide and accumulate in rheumatoid arthritis and immunosenescence.Synovial cellular and molecular markers in rheumatoid arthritis.Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis.Combination of infliximab with thiopurines significantly reduces white cell and neutrophil counts in inflammatory bowel disease patients.Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Rheumatoid Arthritis.Transmembrane TNF-dependent uptake of anti-TNF antibodies.The new ACR/EULAR criteria for rheumatoid arthritis can identify patients with same disease activity but less damage by ultrasound.Monocyte-related biomarkers of rheumatoid arthritis development in undifferentiated arthritis patients - a pilot study.
P2860
Q26774681-265D1EB2-F2B7-42EF-9900-B8BFD8AE4BD2Q34505966-6E55F997-E5D4-434D-9DD5-0E597E25DAC0Q34688901-0CE18BA7-2875-4A4D-8A0A-16AF1B0795F8Q34694718-E26C0E05-982C-4D3E-8B45-ACC37BB188F4Q36142652-2EE38665-AC22-458D-A8DD-3D8C06292E8AQ37690163-5C9D2A2B-4425-4737-A998-E00904E49303Q39301702-9BDBCD64-7B27-4E99-802F-01B229E3AFC6Q39704305-8C5F5381-7B14-42C7-AE81-12C5A2C656C3Q39725107-BF513AF2-BA66-464B-97C9-4F22BC0B3574Q41883420-AEA04D04-0948-4F7C-B310-7CE4666B459BQ41920795-1522BBCC-F9B0-4EEE-92B7-4A1CFAC654BDQ42199102-C51B1B5B-733E-4CE0-A939-CB48CE7E85BDQ52568468-D47C7B35-552D-42CB-A11D-57F823F70E8B
P2860
Differential effects of infliximab on absolute circulating blood leucocyte counts of innate immune cells in early and late rheumatoid arthritis patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Differential effects of inflix ...... rheumatoid arthritis patients.
@en
Differential effects of inflix ...... rheumatoid arthritis patients.
@en-gb
Differential effects of inflix ...... rheumatoid arthritis patients.
@nl
type
label
Differential effects of inflix ...... rheumatoid arthritis patients.
@en
Differential effects of inflix ...... rheumatoid arthritis patients.
@en-gb
Differential effects of inflix ...... rheumatoid arthritis patients.
@nl
prefLabel
Differential effects of inflix ...... rheumatoid arthritis patients.
@en
Differential effects of inflix ...... rheumatoid arthritis patients.
@en-gb
Differential effects of inflix ...... rheumatoid arthritis patients.
@nl
P2093
P2860
P50
P1476
Differential effects of inflix ...... rheumatoid arthritis patients.
@en
P2093
A W Morgan
D L Cooper
L D Church
L J Dickie
L R Coulthard
R J Mathews
P2860
P356
10.1111/J.1365-2249.2012.04626.X
P577
2012-10-01T00:00:00Z
P5875
P6179
1002556577